ArticlePlastic and reconstructive surgery. Global open2026
Novel Porcine Xenograft as a Salvage Strategy for Lower Extremity Wound Reconstruction Following Free Flap Failure.
Article in Plastic and reconstructive surgery. Global open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lower extremity wounds involving the proximal and middle tibia remain a reconstructive challenge, especially following free flap failure. Traditional salvage strategies are limited in patients with comorbidities or wound contamination. Porcine-derived xenografts, such as XCellistem, offer a biologically active scaffold to promote granulation tissue and enable secondary grafting. Methods: This case series included 2 male patients with complex tibial wounds and failed anterolateral thigh free flaps. Both underwent surgical debridement followed by multilayered application of the porcine xenograft XCellistem. Wounds were monitored for granulation tissue development and subsequently reconstructed using split-thickness skin grafts. Patients were followed up for at least 6 months to assess wound durability and limb function. Results: Both patients demonstrated successful granulation tissue formation, with one requiring serial applications. No major complications were observed, and both patients achieved stable wound coverage. Skin grafting was performed on postoperative day 16 and at week 12, respectively. Long-term follow-up confirmed durable healing and satisfactory functional outcomes. Conclusions: XCellistem porcine xenograft is a promising salvage option for lower extremity wounds after flap failure. It facilitates timely granulation, enables skin grafting, and may reduce the need for further microsurgical intervention. Larger studies are needed to validate these findings and expand limb salvage strategies.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.